| 17.04.2024 14:23 | BVX | Bivictrix granted FDA orphan drug status for rare cancer treatment | Alliance |
| 17.04.2024 07:00 | BVX | Orphan Drug Designation & FDA INTERACT Meeting | RNS |
| 28.03.2024 07:00 | BVX | Grant of Options – PDMR/Director Dealings | RNS |
| 04.01.2024 12:30 | BVX | Holding(s) in Company | RNS |
| 04.01.2024 12:30 | BVX | Holding(s) in Company | RNS |
| 04.01.2024 07:00 | BVX | BiVictriX Hosts Inaugural Roundtable Discussion | RNS |
| 05.12.2023 11:08 | BVX | Board Change | RNS |
| 30.11.2023 12:08 | BVX | IN BRIEF: Bivictrix selects final sequences for lead tumour programme | Alliance |
| 30.11.2023 07:00 | BVX | Pipeline update on BVX002 | RNS |
| 22.11.2023 17:14 | BVX | Holding(s) in Company | RNS |
| 15.11.2023 13:05 | TLW, ROCK, ECO | TRADING UPDATES: BiVictriX patent boost; 4Global deal extended | Alliance |
| 15.11.2023 07:00 | BVX | Patent Granted in Japan | RNS |
| 12.10.2023 12:04 | BVX | Bivictrix says BVX001 increases survival rates by more than double | Alliance |
| 12.10.2023 07:00 | BVX | Extended Survival Rates Reported with BVX001 | RNS |
| 03.10.2023 12:06 | BVX | Bivictrix hires new CFO as Alex Hughes steps down after seven months | Alliance |
| 03.10.2023 07:00 | BVX | Appointment of Adrian Howd as CFO and CBO | RNS |
| 19.09.2023 17:30 | AATG, GRL, EUA | TRADING UPDATES: AEW UK REIT appoints new chair; Oberon raises money | Alliance |
| 19.09.2023 07:00 | BVX | Interim Results | RNS |
| 31.08.2023 07:00 | BVX | Total Voting Rights | RNS |
| 23.08.2023 10:51 | JAY, JSE, BVX | AIM WINNERS & LOSERS: Jadestone Energy up on Montara repairs progress | Alliance |
| 23.08.2023 09:30 | BVX | Bivictrix Therapeutics granted US patent for cancer drug BVX001 | Alliance |
| 23.08.2023 07:00 | BVX | US Patent Granted | RNS |
| 17.08.2023 07:00 | BVX | Holding(s) in Company | RNS |
| 16.08.2023 18:00 | BVX | Holding(s) in Company | RNS |
| 11.08.2023 16:17 | BVX | Holding(s) in Company | RNS |
| 08.08.2023 17:18 | BVX | Result of General Meeting | RNS |
| 19.07.2023 19:30 | BVX | UPDATE: Bivictrix Therapeutics raises GBP2.1 million through fundraise | Alliance |
| 19.07.2023 18:16 | BVX | Result of Conditional Fundraise | RNS |
| 19.07.2023 14:12 | BVX | IN BRIEF: Bivictrix to raise more than GBP2 million via placing | Alliance |
| 19.07.2023 12:31 | BVX | Proposed Fundraise in excess of £2 million | RNS |
| 17.07.2023 13:57 | BVX | Bivictrix Therapeutics hails positive data in final leukaemia study | Alliance |
| 17.07.2023 07:00 | BVX | Positive final data in preclinical efficacy study | RNS |
| 19.06.2023 13:50 | BVX | IN BRIEF: Bivictrix Therapeutics hails positive leukaemia test results | Alliance |
| 19.06.2023 07:00 | BVX | Positive interim data | RNS |
| 06.06.2023 13:52 | BVX | IN BRIEF: Bivictrix selects clinical candidate for leukaemia trial | Alliance |
| 06.06.2023 07:00 | BVX | BiVictriX nominates clinical candidate for BVX001 | RNS |
| 04.05.2023 16:36 | BVX | Result of Annual General Meeting | RNS |
| 27.04.2023 15:49 | WTAN, TPK, SHI | UK shareholder meetings calendar - next 7 days | Alliance |
| 31.03.2023 07:00 | BVX | Publication of Annual Report and Notice of AGM | RNS |
| 30.03.2023 18:39 | BVX, PTAL, RENX | EARNINGS UPDATES: Ironveld sees interim pretax loss widen on costs | Alliance |
| 30.03.2023 07:00 | BVX | BiVictriX Full Year Results | RNS |
| 01.03.2023 16:57 | XSG, AEG, JUST | EXECUTIVE CHANGES: Record founder retires; Bivictrix appoints new CFO | Alliance |
| 01.03.2023 07:01 | BVX | Appointment of Alex Hughes as CFO | RNS |
| 31.01.2023 17:35 | MHC, MTL, HOC | TRADING UPDATES: Bivictrix hails cancer therapy candidate | Alliance |
| 31.01.2023 07:08 | BVX | BiVictriX reports positive BVX001 preclinical data | RNS |
| 24.01.2023 16:21 | BVX | Holding(s) in Company | RNS |
| 19.01.2023 11:00 | BVX | Holding(s) in Company | RNS |
| 19.01.2023 07:00 | BVX | Holding(s) in Company | RNS |
| 16.01.2023 16:32 | BVX | Holding(s) in Company | RNS |
| 06.01.2023 10:23 | BVX | Bivictrix promotes non-executive director to non-executive chair | Alliance |
| 06.01.2023 07:00 | BVX | BiVictriX: Board Change | RNS |
| 12.12.2022 11:37 | BVX | EQS-News: BiVictriX Therapeutics makes 'fundamental step forward' | EQS |
| 07.12.2022 11:12 | MEN, MSI, BVX | AIM WINNERS & LOSERS: Bivictrix surges on lead for BVX001 programme | Alliance |
| 07.12.2022 10:59 | BVX | Bivictrix identifies lead for antibody drug conjugates programme | Alliance |
| 07.12.2022 07:00 | BVX | BiVictriX identifies lead for BVX001 programme | RNS |
| 28.09.2022 10:40 | BVX | Holding(s) in Company | RNS |
| 27.09.2022 07:00 | BVX | Holding(s) in Company | RNS |
| 15.09.2022 15:36 | BVX | Director Dealing | RNS |
| 13.09.2022 07:00 | BVX | Director Dealing | RNS |
| 12.09.2022 14:19 | BVX | BiVictriX Therapeutics reports widening loss following R&D investment | Alliance |
| 12.09.2022 07:00 | BVX | BiVictriX Interim Results | RNS |
| 11.07.2022 21:40 | BVX, KINO, KAV | TRADING UPDATES: Byotrol anticipating positive full-year earnings | Alliance |
| 11.07.2022 07:00 | BVX | Pipeline update | RNS |
| 05.07.2022 09:16 | BVX | Holding(s) in Company | RNS |
| 25.04.2022 09:30 | BVX | BiVictriX AIM Rule 17 Notice | RNS |
| 31.03.2022 14:59 | BVX | Result of AGM | RNS |
| 30.03.2022 13:33 | BVX | Holding(s) in Company | RNS |
| 25.03.2022 17:48 | BVX | Holding(s) in Company | RNS |
| 24.03.2022 15:58 | CLCO, BVX, TOOP | UK shareholder meetings calendar - next 7 days | Alliance |
| 09.03.2022 07:00 | BVX | BiVictriX Director Dealing | RNS |
| 09.03.2022 07:00 | BVX | Publication of Annual Report and Notice of AGM | RNS |
| 07.03.2022 07:00 | BVX | BiVictriX Full Year Results | RNS |
| 23.02.2022 20:11 | AVON, AMC, CZN | TRADING UPDATES: BiVictriX expands development; Okyo wins US patent | Alliance |
| 23.02.2022 07:00 | BVX | Expansion of Therapeutic Pipeline | RNS |
| 21.02.2022 18:13 | PCFT, BVX, SAR | TRADING UPDATES: Bank of Cyprus swings profit; Sareum loss widens | Alliance |
